NCT00709176

Brief Summary

The purpose of this study is to assess the quality of life of patients with advanced cancer and their family caregivers and to evaluate two doses of a family-based program of care versus control.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
484

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2005

Longer than P75 for not_applicable

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2005

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

July 1, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 3, 2008

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2010

Completed
Last Updated

February 11, 2014

Status Verified

October 1, 2013

Enrollment Period

4.9 years

First QC Date

July 1, 2008

Last Update Submit

February 10, 2014

Conditions

Keywords

Quality of LifeRandomized Clinical TrialAdvanced CancerBreast CancerColorectal CancerLung CancerProstate CancerFamily caregivercancer survivorshipcopingcommunicationuncertaintysupportdepressionself-efficacybenefits of illnessCaregivers

Outcome Measures

Primary Outcomes (1)

  • Change in Quality of Life

    Baseline, 3 and 6 months

Secondary Outcomes (13)

  • Risk for Distress

    Baseline

  • Change in Emotional Distress

    Baseline, 3 and 6 months

  • Change in Appraisal of Illness/Caregiving

    Baseline, 3 and 6 months

  • Change in Uncertainty

    Baseline, 3 and 6 months

  • Change in Hopelessness

    Baseline, 3 and 6 months

  • +8 more secondary outcomes

Study Arms (3)

Brief

EXPERIMENTAL

Dyads randomized to BRIEF arm received the Brief FOCUS Program (two home visits and one phone call by a trained nurse) in addition to standard clinical care.

Behavioral: Brief FOCUS Program

Extensive

EXPERIMENTAL

Dyads randomized to EXTENSIVE arm received the Extensive FOCUS Program (4 home visits and two phone calls by a trained nurse) in addition to standard clinical care.

Behavioral: Extensive FOCUS Program

Control

NO INTERVENTION

Dyads randomized to CONTROL arm continued with standard clinical care.

Interventions

Dyads randomized to this arm received the FOCUS Brief Program, two home visits and one phone call by a trained nurse.

Also known as: Family(F),Optimism(O),Coping(C),Uncertainty(U),Symptoms(S), Family-based Intervention, Cancer Patient and Family Member Intervention
Brief

Dyads randomized to this arm received the FOCUS Extensive Program, 4 home visits and two phone calls by a trained nurse.

Also known as: Family(F),Optimism(O),Coping(C),Uncertainty(U),Symptoms(S), Family-based Intervention, Cancer Patient and Family Member Intervention
Extensive

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with Stage 3 or 4 breast, prostate, colorectal and lung cancers.
  • Patients must be 21 years old or older, physically and mentally able to participate, speak and understand English, have a minimum life expectancy of six months, live within 75 miles of one of the participating sites and have a family caregiver who is willing to participate in the study.
  • For this study "family caregiver" is defined as the person who provides the patient with physical and/or emotional support during cancer treatment.
  • Family caregivers must be 18 years old or older, physically and mentally able to participate, and speak and understand English.

You may not qualify if:

  • Patients will be excluded if they have multiple primary cancer sites.
  • Family caregivers will be excluded if they, themselves, have been diagnosed with cancer during the previous year and/or are in active treatment for cancer.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

St. Joseph Mercy Cancer Center

Ann Arbor, Michigan, 48106, United States

Location

University of Michigan Comprehensive Cancer Center

Ann Arbor, Michigan, 48109, United States

Location

Karmanos Cancer Center

Detroit, Michigan, 48202, United States

Location

Wayne State University

Detroit, Michigan, 48202, United States

Location

Providence Hospital Cancer Institute

Southfield, Michigan, 48075, United States

Location

Related Publications (3)

  • Northouse L. Helping families of patients with cancer. Oncol Nurs Forum. 2005 Jul 1;32(4):743-50. doi: 10.1188/05.onf.743-750.

    PMID: 15990903BACKGROUND
  • Northouse LL, Mood DW, Schafenacker A, Kalemkerian G, Zalupski M, LoRusso P, Hayes DF, Hussain M, Ruckdeschel J, Fendrick AM, Trask PC, Ronis DL, Kershaw T. Randomized clinical trial of a brief and extensive dyadic intervention for advanced cancer patients and their family caregivers. Psychooncology. 2013 Mar;22(3):555-63. doi: 10.1002/pon.3036. Epub 2012 Jan 31.

  • Guan T, Chapman MV, de Saxe Zerden L, Zimmer C, Braden CJ, Rizo CF, Northouse L, Song L. Illness uncertainty and quality of life in patients with advanced cancer and their family caregivers: An actor-partner interdependence model analysis. Psychooncology. 2023 Nov;32(11):1744-1751. doi: 10.1002/pon.6228. Epub 2023 Oct 4.

Related Links

MeSH Terms

Conditions

Breast NeoplasmsColorectal NeoplasmsLung NeoplasmsProstatic NeoplasmsCommunicationDepression

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract DiseasesGenital Neoplasms, MaleUrogenital NeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital DiseasesBehaviorBehavioral Symptoms

Study Officials

  • Laurel L Northouse, PhD, RN

    University of Michigan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 1, 2008

First Posted

July 3, 2008

Study Start

June 1, 2005

Primary Completion

May 1, 2010

Study Completion

May 1, 2010

Last Updated

February 11, 2014

Record last verified: 2013-10

Locations